Journal
RETROVIROLOGY
Volume 16, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12977-019-0503-0
Keywords
HTLV-1; STLV-1; ATL; Prevalence; Interspecies transmission; Animal model; Therapy
Categories
Funding
- French Laboratory of Excellence project ECOFECT [ANR11-LABX-0048]
- Fondation pour la recherche medicale [DEQ20180339200]
- Labex Ecofect
- Ecole Normale Superieure de Lyon
- INSERM
Ask authors/readers for more resources
Few years after HTLV-1 identification and isolation in humans, STLV-1, its simian counterpart, was discovered. It then became clear that STLV-1 is present almost in all simian species. Subsequent molecular epidemiology studies demonstrated that, apart from HTLV-1 subtype A, all human subtypes have a simian homolog. As HTLV-1, STLV-1 is the etiological agent of ATL, while no case of TSP/HAM has been described. Given its similarities with HTLV-1, STLV-1 represents a unique tool used for performing clinical studies, vaccine studies as well as basic science.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available